Published on in Vol 10 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/46893, first published .
Evaluating the Usefulness and Ease of Use of a Next-Generation–Connected Drug Delivery Device for Growth Hormone Therapy: Qualitative Study of Health Care Professionals’ Perceptions

Evaluating the Usefulness and Ease of Use of a Next-Generation–Connected Drug Delivery Device for Growth Hormone Therapy: Qualitative Study of Health Care Professionals’ Perceptions

Evaluating the Usefulness and Ease of Use of a Next-Generation–Connected Drug Delivery Device for Growth Hormone Therapy: Qualitative Study of Health Care Professionals’ Perceptions

José I Labarta   1, 2 , MD ;   Paul Dimitri   3 , BSc, MBChB, PhD ;   Matthew Keiser   4 , BS, MS ;   Ekaterina Koledova   5 , MD, PhD ;   Octavio Rivera-Romero   6 , PhD

1 Unit of Endocrinology, Department of Pediatrics, Hospital Universitario Miguel Servet, Zaragoza, Spain

2 Instituto de Investigación Sanitaria Aragón, Zaragoza, Spain

3 Department of Paediatric Endocrinology, Sheffield Children's NHS Foundation Trust, Sheffield, United Kingdom

4 Ares Trading SA (an affiliate of Merck KGaA), Eysins, Switzerland

5 Global Medical Affairs Cardiometabolic & Endocrinology, Merck Healthcare KGaA, Darmstadt, Germany

6 Electronic Technology Department, Universidad de Sevilla, Seville, Spain

Corresponding Author:

  • Octavio Rivera-Romero, PhD
  • Electronic Technology Department
  • Universidad de Sevilla
  • Avda. Reina Mercedes s/n
  • Seville, 41012
  • Spain
  • Phone: 34 954 55 27 89
  • Email: orivera@us.es